Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-24-014017
Filing Date
2024-04-09
Accepted
2024-04-09 08:46:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13g.htm SC 13G 84408
  Complete submission text file 0001493152-24-014017.txt   85723
Mailing Address 101 EAST 52ND ST NEW YORK NY 10022
Business Address
HIRSCHMAN ORIN (Filed by) CIK: 0001131362 (see all company filings)

Type: SC 13G

Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-649-9272
Acasti Pharma Inc. (Subject) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-87760 | Film No.: 24831247
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)